These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 16731836

  • 21. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
    Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert JJ, Holst JJ, Clark PM, Ellard S, Søvik O, Polak M, Hattersley AT, Neonatal Diabetes International Collaborative Group.
    N Engl J Med; 2006 Aug 03; 355(5):467-77. PubMed ID: 16885550
    [Abstract] [Full Text] [Related]

  • 22. Involvement of the n-terminus of Kir6.2 in coupling to the sulphonylurea receptor.
    Reimann F, Tucker SJ, Proks P, Ashcroft FM.
    J Physiol; 1999 Jul 15; 518 ( Pt 2)(Pt 2):325-36. PubMed ID: 10381582
    [Abstract] [Full Text] [Related]

  • 23. [Neonatal diabetes mellitus].
    Huopio H, Otonkoski T.
    Duodecim; 2011 Jul 15; 127(6):534-41. PubMed ID: 21528518
    [Abstract] [Full Text] [Related]

  • 24. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.
    Massa O, Iafusco D, D'Amato E, Gloyn AL, Hattersley AT, Pasquino B, Tonini G, Dammacco F, Zanette G, Meschi F, Porzio O, Bottazzo G, Crinó A, Lorini R, Cerutti F, Vanelli M, Barbetti F, Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology.
    Hum Mutat; 2005 Jan 15; 25(1):22-7. PubMed ID: 15580558
    [Abstract] [Full Text] [Related]

  • 25. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
    Proks P, Arnold AL, Bruining J, Girard C, Flanagan SE, Larkin B, Colclough K, Hattersley AT, Ashcroft FM, Ellard S.
    Hum Mol Genet; 2006 Jun 01; 15(11):1793-800. PubMed ID: 16613899
    [Abstract] [Full Text] [Related]

  • 26. The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): a major ATP-binding residue.
    Shimomura K, de Nanclares GP, Foutinou C, Caimari M, Castaño L, Ashcroft FM.
    Diabet Med; 2010 Feb 01; 27(2):225-9. PubMed ID: 20546268
    [Abstract] [Full Text] [Related]

  • 27. Relapsing diabetes can result from moderately activating mutations in KCNJ11.
    Gloyn AL, Reimann F, Girard C, Edghill EL, Proks P, Pearson ER, Temple IK, Mackay DJ, Shield JP, Freedenberg D, Noyes K, Ellard S, Ashcroft FM, Gribble FM, Hattersley AT.
    Hum Mol Genet; 2005 Apr 01; 14(7):925-34. PubMed ID: 15718250
    [Abstract] [Full Text] [Related]

  • 28. Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP.
    Proks P, Girard C, Ashcroft FM.
    Hum Mol Genet; 2005 Sep 15; 14(18):2717-26. PubMed ID: 16087682
    [Abstract] [Full Text] [Related]

  • 29. Functional modulation of the ATP-sensitive potassium channel by extracellular signal-regulated kinase-mediated phosphorylation.
    Lin YF, Chai Y.
    Neuroscience; 2008 Mar 18; 152(2):371-80. PubMed ID: 18280666
    [Abstract] [Full Text] [Related]

  • 30. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
    Masia R, Koster JC, Tumini S, Chiarelli F, Colombo C, Nichols CG, Barbetti F.
    Diabetes; 2007 Feb 18; 56(2):328-36. PubMed ID: 17259376
    [Abstract] [Full Text] [Related]

  • 31. [Low doses of sulphonyluria as a successful replacement for insulin therapy in a patient with neonatal diabetes due to a mutation of KCNJ11 gene encoding Kir6.2].
    Ille J, Putarek NR, Radica A, Hattersley A, Ellard S, Dumić M.
    Lijec Vjesn; 2010 Feb 18; 132(3-4):90-3. PubMed ID: 20540435
    [Abstract] [Full Text] [Related]

  • 32. Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome.
    Proks P, Shimomura K, Craig TJ, Girard CA, Ashcroft FM.
    Hum Mol Genet; 2007 Aug 15; 16(16):2011-9. PubMed ID: 17584766
    [Abstract] [Full Text] [Related]

  • 33. A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome.
    Proks P, Girard C, Haider S, Gloyn AL, Hattersley AT, Sansom MS, Ashcroft FM.
    EMBO Rep; 2005 May 15; 6(5):470-5. PubMed ID: 15864298
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea receptor 1.
    Park EJ, Bae JH, Kim SY, Lim JG, Baek WK, Kwon TK, Suh SI, Park JW, Lee IK, Ashcroft FM, Song DK.
    Biochem Pharmacol; 2004 Mar 15; 67(6):1089-96. PubMed ID: 15006545
    [Abstract] [Full Text] [Related]

  • 35. An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes reveals a site of interaction between Kir6.2 and SUR1.
    Craig TJ, Shimomura K, Holl RW, Flanagan SE, Ellard S, Ashcroft FM.
    J Clin Endocrinol Metab; 2009 Jul 15; 94(7):2551-7. PubMed ID: 19351728
    [Abstract] [Full Text] [Related]

  • 36. Successful transfer from insulin to oral sulfonylurea in a 3-year-old girl with a mutation in the KCNJ11 gene.
    Al-Mahdi M, Al Mutair A, Al Balwi M, Hussain K.
    Ann Saudi Med; 2010 Jul 15; 30(2):162-4. PubMed ID: 20220270
    [Abstract] [Full Text] [Related]

  • 37. Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.
    Babiker T, Vedovato N, Patel K, Thomas N, Finn R, Männikkö R, Chakera AJ, Flanagan SE, Shepherd MH, Ellard S, Ashcroft FM, Hattersley AT.
    Diabetologia; 2016 Jun 15; 59(6):1162-6. PubMed ID: 27033559
    [Abstract] [Full Text] [Related]

  • 38. Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation.
    Slingerland AS, Hurkx W, Noordam K, Flanagan SE, Jukema JW, Meiners LC, Bruining GJ, Hattersley AT, Hadders-Algra M.
    Diabet Med; 2008 Mar 15; 25(3):277-81. PubMed ID: 18307455
    [Abstract] [Full Text] [Related]

  • 39. Identification of mutations in the Kir6.2 subunit of the K(ATP) channel.
    Flanagan SE, Ellard S.
    Methods Mol Biol; 2008 Mar 15; 491():235-45. PubMed ID: 18998097
    [Abstract] [Full Text] [Related]

  • 40. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
    Babenko AP, Polak M, Cavé H, Busiah K, Czernichow P, Scharfmann R, Bryan J, Aguilar-Bryan L, Vaxillaire M, Froguel P.
    N Engl J Med; 2006 Aug 03; 355(5):456-66. PubMed ID: 16885549
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.